Cutler Group LP Tyme Technologies, Inc. Call Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Jul 19, 2021
SELL
$1.14 - $1.87 $10,488 - $17,204
-9,200 Reduced 76.03%
2,900 $0
Q1 2021

Apr 26, 2021
BUY
$1.34 - $3.53 $15,946 - $42,007
11,900 Added 5950.0%
12,100 $1,000
Q1 2020

May 07, 2020
SELL
$0.9 - $1.95 $90 - $195
-100 Reduced 33.33%
200 $0
Q3 2019

Oct 28, 2019
BUY
$0.97 - $1.77 $291 - $531
300 New
300 $0

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email